Described herein are T cells engineered to express a chimeric antigen receptor (CAR), such as an anti-mesothelin CAR alone or in combination with a follicle-stimulating hormone receptor (FSHR) binding domain and/or a dominant negative transforming growth factor-β receptor II (dnTGFβRII) for the treatment of diseases associated with mesothelin expression. Also described are T cells engineered to express a modified T cell receptor (TCR).本文描述經工程改造以表現嵌合抗原受體(CAR)諸如抗間皮素CAR單獨或與濾泡刺激素受體(FSHR)結合域及/或顯性負性轉型生長因子-β受體II(dnTGFβRII)組合的T細胞,其係用於治療與間皮素表現有關之疾病。亦描述經工程改造以表現經修飾之T細胞受體(TCR)的T細胞。